Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from LTR Pharma Limited ( (AU:LTP) ) is now available.
LTR Pharma Limited has announced a change in the director’s interest notice, specifically regarding Lee Rodne. The company has issued 2,000,000 unlisted options to the director under the Employee Incentive Plan, which was approved by shareholders at the 2025 Annual General Meeting. This move reflects a strategic decision to align the director’s interests with the company’s long-term goals, potentially impacting the company’s governance and stakeholder confidence.
More about LTR Pharma Limited
Average Trading Volume: 848,857
Technical Sentiment Signal: Sell
Current Market Cap: A$88.08M
For detailed information about LTP stock, go to TipRanks’ Stock Analysis page.